Cirrhosis and lesion characterization at MR imaging

Radiographics

Volumn 29, Issue 6, 2009, Pages 1637-1652

  Hussain, Shahid M ^a   Reinhold, Caroline ^b   Mitchell, Donald G ^c  

^a NEBRASKA MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; IMAGE ENHANCEMENT; LIVER; LIVER CIRRHOSIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING;

EID: 77449121552     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.296095508     Document Type: Article

References (50)

1. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2002;10:31-52.
2. Hussain SM, Zondervan PE, Ijzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. RadioGraphics 2002;22: 1023-1036.
3. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
5. Kageyama F, Kobayashi Y, Kawasaki T, et al. An unusual hyperplastic hepatocellular nodule in a patient with hepatitis C virus-related liver cirrhosis. Am J Gastroenterol 1998;93:2588-2593.
6. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991;14:969-974.
7. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-1491.
8. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1974-94. Lancet 1997;350:1142-1143.
9. Choi BI, Takayasu K, Han MC. Small hepatocellular carcinomas and associated lesions of the liver: pathology, pathogenesis, and imaging findings. AJR Am J Roentgenol 1993;160:1177-1187.
10. Mitchell DG. Liver I. Currently available gadolinium chelates. Magn Reson Imaging Clin N Am 1996;4:37-51.
11. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703.
12. Mitchell DG. MR imaging of cirrhosis and its complications. Abdom Imaging 2000;25:455.
13. Hussain SM. Liver MRI: correlation with other imaging modalities and histopathology. Berlin, Germany: Springer-Verlag, 2007.
14. van den Bos IC, Hussain SM, Terkivatan T, Zondervan PE, de Man RA. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. J Magn Reson Imaging 2006;24:1071-1080.
15. Hussain SM, De Becker J, Hop WC, Dwarkasing S, Wielopolski PA. Can a single-shot black-blood T2weighted spin-echo echo-planar imaging sequence with sensitivity encoding replace the respiratorytriggered turbo spin-echo sequence for the liver? an optimization and feasibility study. J Magn Reson Imaging 2005;21:219-229.
16. Trevisani F, Cantarini MC, Wands JR, Bernardi M. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 2008;29:1299-1305.
17. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-993.
18. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 18,900 necropsies. Cancer 1954;7:462-503.
19. Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer 1987;60:810-819.
20. Ito K, Fujita T, Shimizu A, et al. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol 2004;183: 699-705.
21. van den Bos IC, Hussain SM, Krestin GP, Wielopolski PA. Liver imaging at 3.0 T: diffusion-induced black-blood echo-planar imaging with large anatomic volumetric coverage as an alternative for specific absorption rate-intensive echo-train spin-echo sequences-feasibility study. Radiology 2008;248: 264-271.
22. Imai Y, Murakami T, Yoshida S, et al. Superpara-magnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-212.
23. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991;178:493-497.
24. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-963.
25. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178.
26. Matsui O, Kadoya M, Kameyama T, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989;173:123-126.
27. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 1996;201:207-214.
28. van den Bos IC, Hussain SM, Dwarkasing RS, et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007;26:1548-1555.
29. Muramatsu Y, Nawano S, Takayasu K, et al. Early hepatocellular carcinoma: MR imaging. Radiology 1991;181:209-213.
30. Ebara M, Fukuda H, Kojima Y, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999;210:81-88.
31. Ito K, Mitchell DG, Gabata T, et al. Hepatocellular carcinoma: association with increased iron deposition in cirrhotic liver at MR imaging. Radiology 1999;212:235-240.
32. Yamashita Y, Fan ZM, Yamamoto H, et al. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 1994;4:83-90.
33. Choi SH, Lee JM, Yu NC, et al. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 2008;191:529-536.
34. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of whole liver. Radiology 1996;200:79-84.
35. Kang BK, Lim JH, Kim SH, et al. Preoperative depiction of hepatocellular carcinoma: ferumoxidesenhanced MR imaging versus triple-phase helical CT. Radiology 2003;226:79-85.
36. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. RadioGraphics 2008;28:747-769.
37. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000;216: 154-162.
38. Tang Y, Yamashita Y, Arakawa A, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadoliniumand ferumoxidesenhanced MR imaging. AJR Am J Roentgenol 1999; 172:1547-1554.
39. Kim YK, Kim CS, Kwak HS, Lee JM. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced MR imaging. J Magn Reson Imaging 2004; 20:826-837.
40. Mitchell DG, Rubin R, Siegelman ES, Burk DL Jr, Rifkin MD. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 1991; 178:101-103.
41. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992; 183:819-825.
42. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 2008;14:1652-1656.
43. Kaczynski J, Hansson G, Wallerstedt S. Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor: an autopsy study from a low endemic area. Acta Oncol 1995; 34:43-48.
44. Lee YT, Geer DA. Primary liver cancer: pattern of metastasis. J Surg Oncol 1987;36:26-31.
45. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005;237: 938-944.
46. Choi D, Mitchell DG, Verma SK, et al. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations. Radiology 2007;244:776-783.
47. Cottone M, Virdone R, Fusco G, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis: a comparison of natural history and surgical treatment. Gastroenterology 1989;96:1566-1571.
48. Winston CB, Schwartz LH, Fong Y, Blumgart LH, Panicek DM. Hepatocellular carcinoma: MR imaging findings in cirrhotic and noncirrhotic livers. Radiology 1999;210:75-79.
49. Terkivatan T, van den Bos IC, Hussain SM, Wielopolski PA, de Man RA, Ijzermans JN. Focal nodular hyperplasia: lesion characteristics on stateof-the-art MRI including dynamic gadoliniumenhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. J Magn Reson Imaging 2006;24:864-872.
50. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006;16:1873-1886.